Sun Pharma enters into settlement with Certain complainants in Antitrust Litigation Matter
New Delhi : Sun Pharmaceutical Industries said the company and its arm entered into settlements with certain plaintiffs in an antitrust litigation matter currently pending in the United States.
"Sun Pharmaceutical Industries Ltd, and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation matter currently pending in the United States District Court for the Eastern District of Pennsylvania," Sun Pharmaceutical Industries said in a BSE filing today.
According to the statement, the settlements extend to all claims brought by Apotex Corporation and the Retailer Purchaser Plaintiffs.
The terms of the settlements are confidential, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd